These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain. Cheeseman AJ, Clark JB. J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694 [Abstract] [Full Text] [Related]
8. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain. Riachi NJ, LaManna JC, Harik SI. J Pharmacol Exp Ther; 1989 Jun; 249(3):744-8. PubMed ID: 2786562 [Abstract] [Full Text] [Related]
9. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+. Nakamura S, Vincent SR. Neurosci Lett; 1986 Apr 24; 65(3):321-5. PubMed ID: 3487052 [Abstract] [Full Text] [Related]
10. Evidence for retrograde axonal transport of MPP+ in the rat. Campbell KJ, Takada M, Hattori T. Neurosci Lett; 1990 Oct 16; 118(2):151-4. PubMed ID: 2274262 [Abstract] [Full Text] [Related]
11. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey. Hartvig P, Larsson BS, Lindberg BS, Oreland L, Gullberg P, Långström B, Rimland A, Lundqvist H, Malmborg P, Lindquist NG. Acta Neurol Scand; 1986 Jul 16; 74(1):10-6. PubMed ID: 3490110 [Abstract] [Full Text] [Related]
12. 1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture. Mytilineou C, Cohen G, Heikkila RE. Neurosci Lett; 1985 Jun 04; 57(1):19-24. PubMed ID: 3875812 [Abstract] [Full Text] [Related]
13. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice. Lee EH. Neurosci Lett; 1988 Jun 07; 88(3):297-302. PubMed ID: 3260360 [Abstract] [Full Text] [Related]
15. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity. Kinemuchi H, Arai Y, Toyoshima Y. Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524 [Abstract] [Full Text] [Related]
17. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Kass GE, Wright JM, Nicotera P, Orrenius S. Arch Biochem Biophys; 1988 Feb 01; 260(2):789-97. PubMed ID: 2963592 [Abstract] [Full Text] [Related]
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon. Schinelli S, Zuddas A, Kopin IJ, Barker JL, di Porzio U. J Neurochem; 1988 Jun 01; 50(6):1900-7. PubMed ID: 3259619 [Abstract] [Full Text] [Related]
19. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE. Life Sci; 1988 Jun 01; 42(3):263-71. PubMed ID: 3121972 [Abstract] [Full Text] [Related]
20. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ, Heavens RP, McBride CS. Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]